Old Second National Bank Of Aurora Has Boosted By $331,872 Its General Electric Co (GE) Position; Stemline Therapeutics (STML)’s Sentiment Is 1.24

February 20, 2018 - By Michael Collier

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercialization of proprietary oncology therapeutics in the United States. The company has market cap of $460.65 million. The firm develops SL-401, a targeted therapy directed to the interleukin-3 receptor , which is in Phase II clinical trial for patients with blastic plasmacytoid dendritic cell neoplasm, myeloproliferative neoplasms, and acute myeloid leukemia; and in Phase I clinical trial in combination with other agents for patients with relapsed/refractory multiple myeloma. It currently has negative earnings. It also develops SL-801, a novel oral small molecule reversible inhibitor of a tumor-promoting nuclear transport protein, which is in Phase I clinical trial for the treatment of solid and hematologic cancers; and SL-701, an immunotherapy that is in Phase II clinical trial to attack brain cancer.

Old Second National Bank Of Aurora increased General Electric Co (GE) stake by 12.28% reported in 2017Q3 SEC filing. Old Second National Bank Of Aurora acquired 13,828 shares as General Electric Co (GE)’s stock declined 7.64%. The Old Second National Bank Of Aurora holds 126,462 shares with $3.06M value, up from 112,634 last quarter. General Electric Co now has $130.52B valuation. The stock increased 1.35% or $0.2 during the last trading session, reaching $15.05. About 64.72M shares traded. General Electric Company (NYSE:GE) has declined 4.46% since February 20, 2017 and is downtrending. It has underperformed by 21.16% the S&P500.

Analysts await Stemline Therapeutics, Inc. (NASDAQ:STML) to report earnings on March, 15. They expect $-0.67 EPS, down 19.64% or $0.11 from last year’s $-0.56 per share. After $-0.68 actual EPS reported by Stemline Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -1.47% EPS growth.

The stock decreased 0.31% or $0.05 during the last trading session, reaching $15.9. About 201,545 shares traded. Stemline Therapeutics, Inc. (STML) has risen 52.65% since February 20, 2017 and is uptrending. It has outperformed by 35.95% the S&P500.

Lyon Street Capital Llc holds 2.32% of its portfolio in Stemline Therapeutics, Inc. for 541,462 shares. Eventide Asset Management Llc owns 1.09 million shares or 0.68% of their US portfolio. Moreover, Sphera Funds Management Ltd. has 0.48% invested in the company for 300,000 shares. The New York-based Knott David M has invested 0.36% in the stock. Carl Domino Inc, a Florida-based fund reported 26,000 shares.

Since January 1, 0001, it had 0 insider buys, and 5 selling transactions for $511,958 activity.

Since August 22, 2017, it had 1 buy, and 0 insider sales for $43,446 activity. The insider TISCH JAMES S bought $2.46M. $43,446 worth of General Electric Company (NYSE:GE) was bought by DIMITRIEF ALEXANDER on Friday, January 26.

Investors sentiment decreased to 0.69 in 2017 Q3. Its down 0.10, from 0.79 in 2017Q2. It turned negative, as 112 investors sold GE shares while 818 reduced holdings. 118 funds opened positions while 525 raised stakes. 4.70 billion shares or 1.82% more from 4.61 billion shares in 2017Q2 were reported. The New Jersey-based Peapack Gladstone has invested 1.59% in General Electric Company (NYSE:GE). Moreover, Private Wealth Advsrs Inc has 1.54% invested in General Electric Company (NYSE:GE). Ronna Sue Cohen owns 146,192 shares. Moreover, Visionary Asset Management has 0.66% invested in General Electric Company (NYSE:GE). Bingham Osborn And Scarborough Limited Com has invested 0.07% of its portfolio in General Electric Company (NYSE:GE). Family Firm Inc reported 19,955 shares. Elm Advsr Limited Liability Company has 20,367 shares. Maryland-based Montgomery Invest Management has invested 0.51% in General Electric Company (NYSE:GE). Heritage Investors Corporation reported 716,391 shares. Jpmorgan Chase And stated it has 56.67M shares or 0.3% of all its holdings. Telos Cap Mngmt reported 1.75% stake. Williams Jones & Associate Lc, New York-based fund reported 421,936 shares. Strategic Glob Advsr Lc has invested 0.1% in General Electric Company (NYSE:GE). Motley Fool Wealth Management Ltd Liability owns 19,460 shares for 0.04% of their portfolio. Gould Asset Management Ltd Llc Ca, California-based fund reported 15,329 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: